Divergences in Insulin Resistance Between the Different Phenotypes of the Polycystic Ovary Syndrome

Moghetti, Paolo, Tosi, Flavia, Bonin, Cecilia, Di Sarra, Daniela, Fiers, Tom, Kaufman, Jean-Marc, Giagulli, Vito Angelo, Signori, Chiara, Zambotti, Francesca, Dall'Alda, Marlene, Spiazzi, Giovanna, Zanolin, Maria Elisabetta, Bonora, Enzo·2013·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2012-3908

Cited by (262)

Items 201–262 of 262

  1. Development and validation of a nomogram for the prediction of metabolic syndrome in polycystic ovary syndrome in a Chinese population
    Jinglu Yu, Zimeng Pan, Miao Sun, Yan Li, Ying Wang, Fangyun Gu, Xiaoling Feng, Hongying Kuang, Lihui Hou · 2025 · Expert Review of Molecular Diagnostics
  2. Divergent pathophysiological drivers of polycystic ovary syndrome: insulin resistance independently fuels the hyperandrogenic phenotype whilst neuroendocrine factors dominate non-hyperandrogenic presentations
    Xiaoxia Wang, Hua Nie, Rong Cui, Guifang Ye, Ying Tan, Jing Zhang, Biyun Zhang, Xingming Zhong · 2026 · Frontiers in Endocrinology
  3. Cross-talking between polycystic ovarian syndrome and gut microbiome: a comprehensive review
    Sudrita Roy Choudhury, Samarpita Koner, Rajen Dey · 2026 · Middle East Fertility Society Journal
  4. Phenotype-Specific Profiles of Isthmin-1, Trimethylamine N-Oxide, and Nitric Oxide in Polyendocrine Metabolic Ovarian Syndrome (Formerly PCOS): An Exploratory Biomarker Study
    Alihan Tığlı, Yakup Baykuş, Rulin Deniz, Güzide Ece Akıncı, Nazlı Şener, Yasemin Ercan Değirmenci, Oğuzhan Karakoç, Muhammet Bora Uzuner, Sefer Üstebay, Sermin Kilic et al. · 2026 · Metabolites
  5. PCOS: dalla patogenesi alla terapia, quali novità
    Paolo Moghetti · 2014 · L Endocrinologo
  6. Clinicobiochemical Analysis of Polycystic Ovary Syndrome and Metabolic Syndrome: Do They Go “Hand in Glove”?
    Nina Mishra, Ruchi Mishra · 2022 · Journal of South Asian Federation of Obstetrics and Gynaecology
  7. Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
    Krystallenia Alexandraki, Eleitho Practice, Athens, Greece, Eleni Kandaraki, Kalliopi‐Anna Poulia, Christina Piperi, Eirini Papadimitriou, Theo Papaioannou · 2021 · touchREVIEWS in Endocrinology
  8. Disorders of carbohydrate metabolism and candidate genes for the pathophysiology of polycystic ovary syndrome. A literature review
    Абашова Елена Ивановна, Maria Igorevna Yarmolinskaya, Natalia S. Osinovskaya · 2023 · Journal of obstetrics and women s diseases
  9. Resting energy expenditure in women with polycystic ovary syndrome
    Flavia Tosi, Federica Rosmini, Veronica Gremes, Federico Lucarini, Martina Zandonà, Maria Elisabetta Zanolin, Tom Fiers, Jean‐Marc Kaufman, Paolo Moghetti · 2024 · Human Reproduction
  10. Disorders of the Ovary
    Sinead Mary McGlacken-Byrne, Harriet Mary Gunn, Helen Simpson · 2024 · Endocrinology
  11. Polycystic ovary syndrome as a diabetes risk factor
    Paolo Moghetti, Flavia Tosi · 2013 · Expert Review of Endocrinology & Metabolism
  12. Diabetes Secondary to Endocrine Disorders and PCOS
    Paolo Moghetti · 2018 · Endocrinology
  13. Polycystic ovary syndrome and cardiovascular risk
    Polina Popova, Inga V. Gorelova, Elena Nikolaevna Grineva · 2019 · Arterial’naya Gipertenziya (Arterial Hypertension)
  14. HYPERINSULINEMIA AND ITS ASSOCIATION WITH POLY CYSTIC OVARIAN SYNDROME
    Ambreen Amna · 2018 · The Professional Medical Journal
  15. Monocyte high density lipoprotein ratio and neutrophil lymphocyte ratio a novel marker in polycystic ovary syndrome
    S. N. S. Minnalkodi, G Arthi. · 2022 · Indian Journal of Obstetrics and Gynecology Research
  16. Polycystic Ovary Syndrome, Obesity and Insulin Resistance
    Samantha Cassar · 2014 · Victoria University Research Repository (Victoria University)
  17. Metformin Improves Glucose Effectiveness, Not Insulin Sensitivity: Predicting Treatment Response in Women With Polycystic Ovary Syndrome
    Jessica M. Duran · 2019 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
  18. Cardiovascular risk in young women with Polycystic OvarySyndrome
    Rose-Marie Kate Coulson · 2014 · ORCA Online Research @Cardiff (Cardiff University)
  19. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances Síndrome dos ovários policísticos: revisando o diagnóstico e o manejo dos distúrbios metabólicos
    Poli Mara Spritzer · 2014
  20. Unravelling the link between insulin resistance and androgen excess
    Michael O’Reilly · 2015 · University of Birmingham Institutional Research Archive (University of Birmingham)
  21. Resistencia a la insulina en la mujer: ¿cómo y cuándo evaluarla?
    Liliana Fung, Rita Pizzi, Indira Centeno, Evelyn Hernández · 2015 · Revista de Obstetricia y Ginecología de Venezuela
  22. Referral bias in female functional hyperandrogenism and polycystic ovary
    Manuel Luque‐Ramírez, Macarena Alpañés, Raúl Sánchón, Elena Fernández‐Durán, A.E. Ortiz-Flores, Héctor Francisco Escobar-Morreale · 2015
  23. Can any meta-analysis help us manage polycystic ovary syndrome?
    Shahla Nader · 2018 · Fertility and Sterility
  24. Gestational Diabetes Mellitus in Women with Polycystic Ovary Syndrome Undergoing Assisted Reproduction
    Tran Thi Minh Chau, Lan N. Vuong · 2018 · Y HOC TP HO CHI MINH
  25. Das polyzystische Ovarsyndrom: Aktuelle Evidenz und praktische Empfehlungen
    Susanne Tan, Christian Böing, Dagmar Führer‐Sakel · 2020 · Diabetologie und Stoffwechsel
  26. Gut metabolites are more predictive of disease- and cohoused- states than gut bacterial features in a mouse model of polycystic ovary syndrome
    Bryan Ho, Daniel Ryback, Basilin Benson, Pedro J. Torres, Robert A. Quinn, Varykina G. Thackray, Scott Theodore Kelley · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Effect of healthy lifestyle promotion on anthropometric variables, eating behavior and cardiometabolic risk factors in women with polycystic ovarian syndrome
    Latifa Imen Benharrat, Azzedine Senouci, Wassila Benhabib, Khedidja Mekki · 2020 · The North African Journal of Food and Nutrition Research
  28. A kaleidoscopic view of ovarian genes associated with polycystic ovary syndrome
    Sezcan Mümüşoğlu, Qingling Yang, Aaron J.W. Hsueh · 2021 · F&S Reviews
  29. Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
    Rhiannon Kate Patten · 2021 · Victoria University Research Repository (Victoria University)
  30. Utilização do sequenciamento em larga escala como ferramenta para identificação de causas monogênicas da síndrome de ovários policísticos
    Raiane Pina Crêspo Teixeira · 2021
  31. Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
    Alexandra Gannon, Shaji K. Chacko, Inka C. Didelija, Juan C. Marini, Chellakkan Selvanesan Blesson · 2022 · Journal of Visualized Experiments
  32. Is There Any Relation Between Insulin Resistance and Menstrual Irregularity in Obese Women?
    Fariba Almassinokiani, Peyman Akbari, Fahimeh Soheilipour · 2020 · Research Square
  33. Diabetes Secondary to Endocrine Disorders and PCOS
    Paolo Moghetti · 2018 · Endocrinology
  34. Diabetes Secondary to Endocrine Disorders and PCOS
    Paolo Moghetti · 2020 · Endocrinology
  35. Diabetes Secondary to Endocrine Disorders and PCOS
    Paolo Moghetti · 2019 · Endocrinology
  36. Exercise interventions in women with Polycystic Ovary Syndrome
    Alba Moreno‐Asso, Rhiannon Kate Patten, Luke C. McIlvenna · 2022 · Elsevier eBooks
  37. Clinical, endocrinal and radiological profile of cases with polycystic ovary syndrome in tertiary care centre
    Raviraj Khairnar, Archana Khairnar · 2023 · The New Indian Journal of OBGYN
  38. Temas selectos de ginecología y obstetricia
    Doctor particular, Abel Agustín Estrada Paneque, Roberto Eduardo Aguirre Fernández, Universidad Técnica de Machala, Mirtha Johnson Quiñones, Doctor particular, Pedro Leandro Núñez Betancourt, Doctor particular, Miguel Eduardo Aguirre Posada, Doctor particular · 2022
  39. Disorders of the Ovary
    Sinead Mary McGlacken-Byrne, Harriet Mary Gunn, Helen Simpson · 2023 · Endocrinology
  40. CYP17A1 Network Analysis in Ovarian Serous Cystadenocarcinoma for Retrieval of Polycystic ovaries Targets
    Zafar Abbas Shah, Asima Tayyab · 2024 · Albus Scientia
  41. CONSUMO ALIMENTAR E A PRÁTICA DE ATIVIDADE FÍSICA DE MULHERES COM SÍNDROME DO OVÁRIO POLICÍSTICO
    Tayná Martins Silva, Thaisa Borges Rocha, Michelle Godoi Branquinho Jota, Marianne de Oliveira Falco · 2024 · Revista Estudos - Revista de Ciências Ambientais e Saúde (EVS)
  42. Use of GLP-1 Receptor Agonists in the Treatment of Obesity in Women with PCOS
    Aleksandra Jaroń, Agata Wiklińska, Katarzyna Jastrzębska, Maria Witkowska, Joanna Skotnicka, Karolina Błaszczak, Monika Turek, Klara Wojciechowska, Adrian Borkowski, Mateusz Sawicki · 2024 · Quality in Sport
  43. The Effects of Nateglinide and Octreotide on the Uterus in Rats with Experimentally Developed Polycystic Ovary Syndrome: A Histopathological Study
    Ömür Gülsüm Deniz, Pınar Kirici, Ebru Elibol Annaç, Selçuk Kaplan · 2025 · The European Research Journal
  44. Metabolic complications in a large cohort of Portuguese women with hirsutism-related disorders
    Joana Pinto, Nicoletta Cera, Duarte Pignatelli · 2025 · Journal of Endocrinological Investigation
  45. Gut and Vaginal Microbiome Dysbiosis in PCOS
    Dulani Kottahachchi, Chandrika Subasinghe, Sarita Bajaj · 2025 · BENTHAM SCIENCE PUBLISHERS eBooks
  46. Novel Therapeutic Intervention for PCOS-1
    Sarita Bajaj · 2025 · BENTHAM SCIENCE PUBLISHERS eBooks
  47. The role of combined Metformin and pharmaceutical molecules with anti-androgenic properties in the therapy of PCOS in adult women
    Athanasios Antoniou-Tsigkos, Γεώργιος Καρράς, Maria Papagianni, PANAGIOTIS F. CHRISTOPOULOS, N. F. Vlahos, George M. Mastorakos · 2025 · Endocrine
  48. Cardiometabolic Health in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review of the Current Research
    月媛 王 · 2026 · Advances in Clinical Medicine
  49. Altered metabolic health during pregnancy in mice with lean polycystic ovary syndrome-like traits from high prenatal AMH
    Emma J Houston, Emily Jewett, Faria Athar, Nicole M. Templeman · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Rôle des adipocytokines dans l'obésité, l'insulino-résistance et leurs conséquences sur la fertilité
    Alice Bongrani · 2022 · theses.fr (ABES)
  51. A computational systems biology view on the role of the menstrual cycle in endocrine health and disease
    Susanna Röblitz · 2026 · Journal of Molecular Endocrinology
  52. ANTI-MÜLLERIAN HORMONE AND HOMA-IR LEVELS IN PCOS PHENOTYPES
    Abdulsattar Al-Sanjary · 2026 · Eastern Ukrainian Medical Journal
  53. Polycystic ovary syndrome
    Ilana Ramer Bass, Emily V. Nosova, Andrea Elizabeth Dunaif · 2026 · Elsevier eBooks
  54. Efficacy of acupuncture therapies for polycystic ovary syndrome: a network meta-analysis
    Ning Yang, Yunxi Li, Hailin Jiang, Rulin Wang, Qi Zhang, Qingqing Tang, Huiying Liu, Yuhong Xie, Sixian Wang, Zhijie Li et al. · 2026 · Frontiers in Medicine
  55. Preconception 1-hour blood glucose as an early indicator of gestational diabetes mellitus risk in PMOS/PCOS women undergoing IVF treatment: a multi-centre cohort study
    Guiquan Wang, Lulu Xie, Yi Chen, Ziyin Ding, Haijie Gao, Haiyan Yang, Peiyu Wang, Xiaohua Gong, Xiaowei Ji, Lin Wang et al. · 2026 · Human Reproduction
  56. Body mass index outperforms the Rotterdam criteria in defining phenotypic heterogeneity in polycystic ovary syndrome: a multicenter study from the Italian PCOS registry (PCOSOUTCOME.net)
    Alessandra Gambineri, Silvia Federici, Elisa Maseroli, Laura Guccione, Marco Bonomi, Anna Maria Fulghesu, Roberta Giordano, Roberto Mioni, Rosario Pivonello, Laura Rotolo et al. · 2026 · Journal of Endocrinological Investigation
  57. Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk
    Maria Forslund, Johanna M. Melin, Anju Elizabeth Joham, Terhi Piltonen, Aled Rees, Helena Jane Teede · 2026 · Journal of Internal Medicine
  58. Insulin signaling in PCOS/PMOS: molecular insights and clinical implications
    Abhishek Goel, Ashna Grover, Skand Shekhar · 2026 · Frontiers in Endocrinology
  59. The Relevance of Follicle Number and Androgens in Metabolic Alterations in Polycystic Ovary Syndrome: A Cross-Sectional Study
    Nicoletta Cera, Joana Pinto, Marica Tina Maccarone, Duarte Pignatelli · 2026 · Journal of Personalized Medicine
  60. Cardiovascular-kidney-metabolic risk in polycystic ovary syndrome: a risk-oriented perspective from integrated Chinese-Western medicine
    Xi Cheng, Yiwen Li, Mengmeng Zhu, 蔡亞潔, Naixuan Wei, Yue Liu, Yue Liu · 2026 · Chinese Herbal Medicines
  61. Phenotype-specific cardiometabolic risk in PMOS (formerly PCOS): an ovarian-endocrine perspective on reproductive and long-term health
    Vincent Kawuribi, Joseph Adu‐Amankwaah, Simon Kumah Yalley · 2026 · Reproductive BioMedicine Online
  62. Asparagus racemosus (Shatavari) in Polycystic Ovary Syndrome: An Evidence-Tiered Translational Review from Phytochemistry to Clinical Trials
    Soumya, Shuchi Upadhyay, Priyanshu, Deepika Kohli, B. S. Rawat · 2026 · International Journal of Translational Medicine